Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 1,352,000 | 1,390,000 | 1,408,000 | 1,376,000 | 1,464,000 |
| Cost of Goods | 1,202,000 | 1,096,000 | 1,085,000 | 1,080,000 | 1,064,000 |
| Gross Profit | 150,000 | 294,000 | 323,000 | 296,000 | 400,000 |
| Operating Expenses | 183,000 | 184,000 | 162,000 | 186,000 | 229,000 |
| Operating Income | -33,000 | 110,000 | 161,000 | 110,000 | 171,000 |
| Interest Expense | 52,000 | 53,000 | 52,000 | 51,000 | 48,000 |
| Other Income | -370,000 | 34,000 | 24,000 | 48,000 | 59,000 |
| Pre-tax Income | -455,000 | 91,000 | 133,000 | 107,000 | 182,000 |
| Income Tax | -137,000 | 15,000 | 37,000 | 13,000 | 40,000 |
| Net Income Continuous | -318,000 | 76,000 | 96,000 | 94,000 | 142,000 |
| Net Income | $-318,000 | $76,000 | $96,000 | $94,000 | $142,000 |
| EPS Basic Total Ops | -1.92 | 0.46 | 0.58 | 0.56 | 0.85 |
| EPS Basic Continuous Ops | -1.92 | 0.46 | 0.58 | 0.56 | 0.85 |
| EPS Diluted Total Ops | -1.90 | 0.46 | 0.57 | 0.55 | 0.83 |
| EPS Diluted Continuous Ops | -1.90 | 0.46 | 0.58 | 0.55 | 0.83 |
| EBITDA(a) | $48,000 | $190,000 | $241,000 | $189,000 | $244,000 |